| Record ID | marc_loc_2016/BooksAll.2016.part34.utf8:89505172:1340 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part34.utf8:89505172:1340?format=raw |
LEADER: 01340cam a22003977a 4500
001 2006922798
003 DLC
005 20081016100410.0
008 060223s2006 gw a b 001 0 eng d
010 $a 2006922798
016 7 $a977471381$2GyFmDB
020 $a9783540309826
020 $a3540309829
020 $a9783540309826
035 $a(OCoLC)ocm69983173
040 $aOHX$cOHX$dBAKER$dUAT$dDLC
042 $alccopycat
050 00 $aRS431.A6$bH68 2006
072 7 $aRS$2lcco
072 7 $aQP$2lcco
082 00 $a615/.329$222
245 00 $aHeterocyclic antitumor antibiotics /$cvolume editor, Moses Lee ; with contributions by D.P. Arya ... [et al.].
260 $aBerlin :$bSpringer,$cc2006.
300 $ax, 252 p. :$bill. ;$c25 cm.
440 0 $aTopics in heterocyclic chemistry,$x1861-9282 ;$v2
504 $aIncludes bibliographical references and indexes.
650 0 $aAntineoplastic agents.
650 0 $aAntibiotics.
650 0 $aAntibacterial agents.
650 0 $aPyrroles$xTherapeutic use.
650 0 $aCarbolines$xTherapeutic use.
650 0 $aDiazo compounds$xTherapeutic use.
650 0 $aBeta lactamases$xInhibitors$xTherapeutic use.
650 0 $aHeterocyclic chemistry.
700 1 $aLee, Moses.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/enhancements/fy0824/2006922798-t.html